Acadia Healthcare (NASDAQ:ACHC) Releases FY24 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $3.40-3.70 for the period, compared to the consensus estimate of $3.54. The company issued revenue guidance of $3.18-3.25 billion, compared to the consensus revenue estimate of $3.22 billion.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ACHC. Stephens raised Acadia Healthcare from an equal weight rating to an overweight rating and set a $92.00 price target on the stock in a research note on Friday, January 5th. TD Cowen lifted their price objective on Acadia Healthcare from $86.00 to $101.00 and gave the company an outperform rating in a research note on Friday, March 1st. Cantor Fitzgerald reaffirmed a neutral rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a sell rating to a hold rating and set a $70.00 price objective on the stock in a research note on Thursday, April 25th. Finally, Barclays began coverage on Acadia Healthcare in a research note on Wednesday, March 6th. They issued an overweight rating and a $100.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare currently has an average rating of Moderate Buy and a consensus target price of $92.00.

Acadia Healthcare Stock Down 1.3 %

ACHC stock traded down $0.95 during midday trading on Wednesday, hitting $72.99. 706,913 shares of the company’s stock were exchanged, compared to its average volume of 571,092. Acadia Healthcare has a 12-month low of $66.49 and a 12-month high of $87.77. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $6.75 billion, a price-to-earnings ratio of -295.99, a price-to-earnings-growth ratio of 2.20 and a beta of 1.31. The firm has a 50 day moving average price of $77.71 and a 200-day moving average price of $77.72.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The business had revenue of $742.80 million during the quarter, compared to the consensus estimate of $727.60 million. During the same period in the previous year, the business earned $0.70 EPS. The business’s quarterly revenue was up 10.0% on a year-over-year basis. On average, analysts anticipate that Acadia Healthcare will post 3.57 EPS for the current year.

Insider Activity

In related news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.00% of the company’s stock.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.